161 related articles for article (PubMed ID: 15750443)
1. Primary high-grade osteosarcoma: comparison between preadolescent and older patients.
Bacci G; Longhi A; Bertoni F; Bacchini P; Ruggeri P; Versari M; Picci P
J Pediatr Hematol Oncol; 2005 Mar; 27(3):129-34. PubMed ID: 15750443
[TBL] [Abstract][Full Text] [Related]
2. Osteosarcoma in preadolescent patients: experience in a single institute in Taiwan.
Hsieh MY; Hung GY; Yen HJ; Chen WM; Chen TH
J Chin Med Assoc; 2009 Sep; 72(9):455-61. PubMed ID: 19762312
[TBL] [Abstract][Full Text] [Related]
3. The extremity localized classic osteosarcomas have better survival than the axial non-classics.
Lin L; Deng S; Zhang F; Liang Y; Huang Z
World J Surg Oncol; 2018 Feb; 16(1):39. PubMed ID: 29471883
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases.
Ward WG; Mikaelian K; Dorey F; Mirra JM; Sassoon A; Holmes EC; Eilber FR; Eckardt JJ
J Clin Oncol; 1994 Sep; 12(9):1849-58. PubMed ID: 8083708
[TBL] [Abstract][Full Text] [Related]
5. Postrelapse Prognostic Factors in Nonmetastatic Osteosarcoma: A Single-institution Experience.
Berlanga P; Cañete A; Salom M; Montalar J; Guasp M; Marco A; Castel V
J Pediatr Hematol Oncol; 2016 Apr; 38(3):176-81. PubMed ID: 26925713
[TBL] [Abstract][Full Text] [Related]
6. What are the factors that affect survival and relapse after local recurrence of osteosarcoma?
Takeuchi A; Lewis VO; Satcher RL; Moon BS; Lin PP
Clin Orthop Relat Res; 2014 Oct; 472(10):3188-95. PubMed ID: 24980644
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemotherapy for osteosarcoma of the extremities in preadolescent patients: the Rizzoli Institute experience.
Bacci G; Balladelli A; Palmerini E; Alberghini M; Pollastri P; Galletti S; Mercuri M; Picci P
J Pediatr Hematol Oncol; 2008 Dec; 30(12):908-12. PubMed ID: 19131777
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma.
Ferrari S; Bertoni F; Zanella L; Setola E; Bacchini P; Alberghini M; Versari M; Bacci G
Cancer; 2004 May; 100(9):1936-42. PubMed ID: 15112275
[TBL] [Abstract][Full Text] [Related]
9. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience.
Mialou V; Philip T; Kalifa C; Perol D; Gentet JC; Marec-Berard P; Pacquement H; Chastagner P; Defaschelles AS; Hartmann O
Cancer; 2005 Sep; 104(5):1100-9. PubMed ID: 16015627
[TBL] [Abstract][Full Text] [Related]
10. Childhood osteosarcoma: multimodal therapy in a single-institution Turkish series.
Ayan I; Kebudi R; Ozger H
Cancer Treat Res; 2009; 152():319-38. PubMed ID: 20213399
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
Bacci G; Longhi A; Versari M; Mercuri M; Briccoli A; Picci P
Cancer; 2006 Mar; 106(5):1154-61. PubMed ID: 16421923
[TBL] [Abstract][Full Text] [Related]
12. Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients.
Bacci G; Longhi A; Cesari M; Versari M; Bertoni F
Cancer; 2006 Jun; 106(12):2701-6. PubMed ID: 16691623
[TBL] [Abstract][Full Text] [Related]
13. Is there a role for chemotherapy after local relapse in high-grade osteosarcoma?
Palmerini E; Torricelli E; Cascinu S; Pierini M; De Paolis M; Donati D; Cesari M; Longhi A; Abate M; Paioli A; Setola E; Ferrari S
Pediatr Blood Cancer; 2019 Aug; 66(8):e27792. PubMed ID: 31058424
[TBL] [Abstract][Full Text] [Related]
14. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
Hung GY; Yen HJ; Yen CC; Chen WM; Chen PC; Wu HT; Chiou HJ; Chang WH; Hsu HE
Ann Surg Oncol; 2015 Apr; 22(4):1080-7. PubMed ID: 25323470
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 overexpression predicts poor survival in patients with high-grade extremity osteosarcoma: a pilot study.
Urakawa H; Nishida Y; Naruse T; Nakashima H; Ishiguro N
Clin Orthop Relat Res; 2009 Nov; 467(11):2932-8. PubMed ID: 19326179
[TBL] [Abstract][Full Text] [Related]
16. A study of 853 high grade osteosarcomas from a single institution-Are outcomes in Indian patients different?
Puri A; Byregowda S; Gulia A; Crasto S; Chinaswamy G
J Surg Oncol; 2018 Feb; 117(2):299-306. PubMed ID: 28833209
[TBL] [Abstract][Full Text] [Related]
17. Pathological fractures in predicting clinical outcomes for patients with osteosarcoma.
Chung LH; Wu PK; Chen CF; Weng HK; Chen TH; Chen WM
BMC Musculoskelet Disord; 2016 Dec; 17(1):503. PubMed ID: 28031047
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in elderly osteosarcoma patients: a multi-institutional retrospective study of 86 cases.
Iwata S; Ishii T; Kawai A; Hiruma T; Yonemoto T; Kamoda H; Asano N; Takeyama M
Ann Surg Oncol; 2014 Jan; 21(1):263-8. PubMed ID: 23975321
[TBL] [Abstract][Full Text] [Related]
19. Survival and prognostic factors in Chinese patients with osteosarcoma: 13-year experience in 365 patients treated at a single institution.
Wang W; Yang J; Wang Y; Wang D; Han G; Jia J; Xu M; Bi W
Pathol Res Pract; 2017 Feb; 213(2):119-125. PubMed ID: 28040328
[TBL] [Abstract][Full Text] [Related]
20. Telangiectatic osteosarcoma.
Mervak TR; Unni KK; Pritchard DJ; McLeod RA
Clin Orthop Relat Res; 1991 Sep; (270):135-9. PubMed ID: 1884532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
